Decibel Cannabis Company has signed a brand licensing agreement with Hilltop Leaf Ltd. to launch its cannabis flower portfolio in the UK, including 15 product lines from its General Admission and Standard Issue brands. The deal supports Decibel's international growth strategy by exporting finished medical cannabis products through Hilltop's EU GMP-certified supply chain, ensuring compliance with UK regulations. The initial launch is planned for Q4 2026, marking a significant step in expanding Decibel's global presence and diversifying its revenue streams.
Decibel Cannabis Company's UK launch news comes alongside today's Health-sector market snapshot on Pluang. As of Oct 08, 2026 18:43 WIB, out of 128 priced US Health-sector stocks, 29 rose and 91 fell. Notable movers include ABEO at USD 5.18 with a 1-day change of +1.97% and 100% buy order activity, ALNY at USD 220.02 down 1.96% with 92% sell orders, and SMMT at USD 17.60 down 1.95% with 98% buy orders. Typical hold times range from 16 to 41 days among these stocks.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
